Company: CWAN
Filing Date: 2025-03-06
Form Type: S-4/A
Source: 0001193125-25-048570
Chunk: 200

Company: Clearwater Analytics Holdings, Inc.
Filing Date: 2025-03-06
Form: S-4/A
Chunk 200
---
 with respect to the Buyer 
 Parties;                                                                                                      |

124

| • |     | the Buyer Parties’ authority to enter into and perform the Merger Agreement; |

| • |     | required consents and regulatory filings in connection with the Merger Agreement and performance thereof; |

| • |     | the absence of any conflict or violation of the Buyer Parties’ organizational documents, existing contracts,                                                                                  
 applicable law or order or the resulting creation of any lien upon the Buyer Parties’ properties or assets due to the execution and delivery of the Merger Agreement and performance thereof; |

| • |     | the capital structure and capitalization of Clearwater; |

| • |     | the capital structure of Acquirer, Merger Sub and Merger Sub II; |

| • |     | the absence of any required vote or approval of holders of voting interests in the Clearwater; |

| • |     | the absence of legal proceedings and orders; |

| • |     | matters with respect to Clearwater’s financing and sufficiency of funds; |

| • |     | the Buyer Parties’ possession of necessary governmental authorizations; |

| • |     | the existence, validity and enforceability of specified categories of Clearwater’s material contracts, and 
 absence of default under any such material contracts;                                                      |

| • |     | delivery and enforceability of the Debt Commitment Letter and the fee letter referred to in the Debt Commitment 
 Letter;                                                                                                         |

| • |     | the solvency of the Buyer Parties and the Surviving Corporation and their respective subsidiaries as of the 
 Effective Time and immediately after the Closing;                                                           |

| • |     | the absence of agreements (other than those contemplated by the Merger Agreement, including the Support                                               
 Agreements and the TRA Amendment) between the Buyer Parties or any of their respective affiliates, and members of Enfusion’s management or directors; |

| • |     | lack of ownership of capital stock of Enfusion; |

| • |     | payment of fees to brokers in connection with the Merger Agreement; |

| • |     | the Buyer Parties’ disclaiming of status as foreign persons (as defined by 31 C.F.R. § 800.224) and                                      
 absence of foreign control (as defined by 31 C.F.R. § 800.208) resulting from the transactions contemplated by the Merger Agreement; and |

| • |     | Clearwater’s compliance with the Securities Act, the Exchange Act and the Sar